openPR Logo
Press release

Porcine Vaccines Market worth $2.70 billion by 2030, growing at a CAGR of 6.72% - Exclusive Report by 360iResearch

03-04-2024 10:27 AM CET | Health & Medicine

Press release from: 360iResearch

Porcine Vaccines Market | 360iResearch

Porcine Vaccines Market | 360iResearch

The "Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Porcine Vaccines Market to grow from USD 1.71 billion in 2023 to USD 2.70 billion by 2030, at a CAGR of 6.72%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/porcine-vaccines?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. These vaccines are created to stimulate the porcine immune system, enabling it to develop defenses against pathogens such as viruses or bacteria that can cause illness. By mimicking the infection, they prepare the swine's body to recognize and combat the actual pathogens should they be encountered in the future. The rise in the incidence of swine diseases and the growing global consumption of pork products are major driving factors behind the need for porcine vaccines. Furthermore, supportive government initiatives, including subsidies and awareness programs, have encouraged the use of vaccines. However, the need for a cold chain infrastructure creates logistical challenges, particularly in developing countries. Furthermore, the variability in the immune response of different pig breeds can impact vaccine effectiveness and create hurdles for the development and adoption of porcine vaccines. However, key players are exploring novel technologies such as nanotechnology, gene editing strategies, and precision medicine to ensure the development of customized vaccines that can overcome the performance challenges of porcine vaccines. Moreover, investigating new adjuvants to enhance immune response without compromising safety and developing needle-free administration could improve vaccine uptake and reduce stress on animals.

In the Americas region, particularly the U.S. and Canada, the porcine vaccine market is well-established due to the extensive pig farming industry and a strong emphasis on animal health management. The country sees a significant consumer need for vaccinations against prevalent diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and others. Producers often adopt the latest vaccines, and purchasing behavior indicates a readiness to invest in advanced solutions for swine herds. Recent research in the U.S. has focused on developing vaccines with improved efficacy and longer immunity periods. Investments in biotechnology companies and government initiatives such as the Veterinary Biologics Program under the United States Department of Agriculture(USDA)-Animal & Plant Health Inspection Service(APHIS) reflect ongoing efforts to strengthen the sector. The EMEA countries represent a diverse market with stringent animal welfare and health regulations. The European consumer requires vaccines that comply with high safety standards, leading to a demand for quality-assured vaccines. The EU's Horizon 2020 program has seen substantial investments in research addressing swine diseases, which propels the development of new and efficient vaccines. In the APAC region, China represents a highly evolved market for pig meat, thereby accentuating the need for porcine markets. India, with an emerging pig farming industry in the APAC region, presents a moderate but growing demand for porcine vaccines. Consumer needs revolve around affordable and accessible vaccines due to cost-sensitive purchasing behaviors. The government has been encouraging the growth of the swine industry through initiatives that provide support for vaccinations and animal health programs.

Market Segmentation & Coverage:

This research report categorizes the Porcine Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Arthritis, Diarrhea, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, and Swine Influenza. The Porcine Circovirus Associated Disease commanded largest market share of 31.57% in 2023, followed by Porcine Reproductive & Respiratory Syndrome.

Based on Technology, market is studied across Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines, Live attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines. The Inactivated Vaccines commanded largest market share of 23.25% in 2023, followed by Live attenuated Vaccines.

Based on End User, market is studied across Hog/Pig Production Farm and Veterinary Clinics/Hospitals. The Hog/Pig Production Farm commanded largest market share of 61.67% in 2023, followed by Veterinary Clinics/Hospitals.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35.55% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/porcine-vaccines?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Porcine Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Porcine Vaccines Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Arko Laboratories, AVAC Vietnam Joint Stock Company, Bayer AG, Bimeda Holdings PLC, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Endovac Animal Health, FATRO S.p.A., Formosa Biomedical Inc., Genvax Technologies, Inc., HIPRA, S.A., Indian Immunologicals Ltd., KM Biologics Co., Ltd., Kyoto Biken Laboratories, Inc., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Medgene Labs, Merck & Co., Inc., Nisseiken Co., Ltd., PBS Animal Health, Phibro Animal Health Corporation, Virbac SA, Yenher Agro-Products Sdn. Bhd., and Zoetis Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Porcine Vaccines Market, by Indication
7. Porcine Vaccines Market, by Technology
8. Porcine Vaccines Market, by End User
9. Americas Porcine Vaccines Market
10. Asia-Pacific Porcine Vaccines Market
11. Europe, Middle East & Africa Porcine Vaccines Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Porcine Vaccines Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Porcine Vaccines Market?
3. What is the competitive strategic window for opportunities in the Porcine Vaccines Market?
4. What are the technology trends and regulatory frameworks in the Porcine Vaccines Market?
5. What is the market share of the leading vendors in the Porcine Vaccines Market?
6. What modes and strategic moves are considered suitable for entering the Porcine Vaccines Market?

Read More @ https://www.360iresearch.com/library/intelligence/porcine-vaccines?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Porcine Vaccines Market worth $2.70 billion by 2030, growing at a CAGR of 6.72% - Exclusive Report by 360iResearch here

News-ID: 3409452 • Views:

More Releases from 360iResearch

Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8.99% - Exclusive Report by 360iResearch
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8 …
The "Laboratory Chemicals Market by Type (Biochemistry, Carbohydrate Analysis, Cell/Tissue Culture), Application (Academia/Educational, Government, Healthcare & Pharmaceutical) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Laboratory Chemicals Market to grow from USD 22.41 billion in 2023 to USD 40.97 billion by 2030, at a CAGR of 8.99%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/laboratory-chemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample Laboratory chemicals include acids, solvents, reagents, and analytical standards for testing and experiments. Laboratory
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,
Disposable Surgical Gloves Market worth $12.56 billion by 2030, growing at a CAGR of 9.84% - Exclusive Report by 360iResearch
Disposable Surgical Gloves Market worth $12.56 billion by 2030, growing at a CAG …
The "Disposable Surgical Gloves Market by Product (Natural Rubber Gloves, Nitrile Disposable Gloves, Vinyl Disposable Gloves), Form (Powdered Gloves, Powdered-Free Gloves), Distribution Channel, End-Users - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Disposable Surgical Gloves Market to grow from USD 6.51 billion in 2023 to USD 12.56 billion by 2030, at a CAGR of 9.84%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/disposable-surgical-gloves?utm_source=openpr&utm_medium=referral&utm_campaign=sample Disposable surgical gloves are used by

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market by Type - Livestock Vaccines and Companion Vac …
According to the report Global Veterinary Vaccines market, published by Market Data Forecast, The Global market has been estimated at USD 5507.3 Million in 2015 and is projected to reach USD 7197.82 Million by 2020, at a CAGR of 5.5% during the forecast period from 2015 to 2020. The Global veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,